Timothy Middleton
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Bill Sugden (6 shared papers)Wu‐Chou Su (1 shared paper)Harrison Echols (1 shared paper)Liangjun Lu (5 shared papers)David Mackey (1 shared paper)Dale J. Kempf (5 shared papers)Lars Sternås (1 shared paper)Akhteruzzaman Molla (4 shared papers)
- Journals
- Journal of Hepatology (5 papers)Journal of Virology (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)Diabetic Medicine (2 papers)Journal of Diabetes and its Complications (2 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Timothy Middleton
25 papers receiving 806 citations
Peers
Comparison fields: 5 of 80
- Hepatology 243
- Infectious Diseases 224
- Oncology 327
- Epidemiology 377
- Virology 32
Countries citing papers authored by Timothy Middleton
This map shows the geographic impact of Timothy Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Middleton more than expected).
Fields of papers citing papers by Timothy Middleton
This network shows the impact of papers produced by Timothy Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Middleton. The network helps show where Timothy Middleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Middleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 110 | |
| 2 | 2014 | 102 | |
| 3 | 1991 | 93 | |
| 4 | 1992 | 85 | |
| 5 | 2007 | 78 | |
| 6 | 1995 | 57 | |
| 7 | 2017 | 57 | |
| 8 | 1990 | 52 | |
| 9 | 2020 | 30 | |
| 10 | 2017 | 30 | |
| 11 | 2015 | 29 | |
| 12 | 2004 | 22 | |
| 13 | 2021 | 18 | |
| 14 | 2010 | 15 | |
| 15 | 1992 | 12 | |
| 16 | 2012 | 9 | |
| 17 | 2021 | 7 | |
| 18 | 2011 | 5 | |
| 19 | 2019 | 4 | |
| 20 | High rate of asymptomatic hypoglycemia in insulin-treated diabetes with severe chronic kidney disease: Utility of flash interstitial glucose monitoring | 2018 | 3 |
About Timothy Middleton
Timothy Middleton is a scholar working on Infectious Diseases, Molecular Biology, Oncology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 28 papers that have together received 829 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Viral-associated cancers and disorders (6 papers), Polyomavirus and related diseases (5 papers), Hepatitis C virus research (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Diabetes Management and Research (3 papers), Birth, Development, and Health (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Hepatology (243 citations), Infectious Diseases (224 citations), Oncology (327 citations), Epidemiology (377 citations) and Virology (32 citations). Timothy Middleton has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Bill Sugden, Wu‐Chou Su, Harrison Echols, Liangjun Lu, David Mackey, Dale J. Kempf, Lars Sternås, Akhteruzzaman Molla, Preethi Krishnan and Stephen M. Twigg. Their work appears in journals such as Journal of Hepatology, Journal of Virology, Antimicrobial Agents and Chemotherapy, Diabetic Medicine and Journal of Diabetes and its Complications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.